Pharma & Healthcare
Global Armodafinil Tablets Market Outlook, In‑Depth Analysis & Forecast to 2031
- Oct 21, 25
- ID: 557433
- Pages: 146
- Figures: 140
- Views: 12
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Armodafinil Tablets market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Cephalon
Mylan
Natco Pharma
Lupin
Aurobindo Pharma
Sandoz
Actavis
Apotex
Segment by Type
50mg per Tablet
150mg per Tablet
200mg per Tablet
250mg per Tablet
Segment by Application
Narcolepsy
Obstructive Sleep Apnea
Shift Work Sleep Disorder
Other
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Armodafinil Tablets study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Armodafinil Tablets market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Cephalon
Mylan
Natco Pharma
Lupin
Aurobindo Pharma
Sandoz
Actavis
Apotex
Segment by Type
50mg per Tablet
150mg per Tablet
200mg per Tablet
250mg per Tablet
Segment by Application
Narcolepsy
Obstructive Sleep Apnea
Shift Work Sleep Disorder
Other
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Armodafinil Tablets study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
1 Study Coverage
1.1 Introduction to Armodafinil Tablets: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Armodafinil Tablets Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 50mg per Tablet
1.2.3 150mg per Tablet
1.2.4 200mg per Tablet
1.2.5 250mg per Tablet
1.3 Market Segmentation by Application
1.3.1 Global Armodafinil Tablets Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Narcolepsy
1.3.3 Obstructive Sleep Apnea
1.3.4 Shift Work Sleep Disorder
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Armodafinil Tablets Revenue Estimates and Forecasts 2020-2031
2.2 Global Armodafinil Tablets Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Armodafinil Tablets Sales Estimates and Forecasts 2020-2031
2.4 Global Armodafinil Tablets Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Armodafinil Tablets Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Armodafinil Tablets Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 50mg per Tablet Market Size by Manufacturers
3.5.2 150mg per Tablet Market Size by Manufacturers
3.5.3 200mg per Tablet Market Size by Manufacturers
3.5.4 250mg per Tablet Market Size by Manufacturers
3.6 Global Armodafinil Tablets Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Armodafinil Tablets Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Armodafinil Tablets Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Armodafinil Tablets Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Armodafinil Tablets Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Armodafinil Tablets Sales and Revenue by Type (2020-2031)
6.4 North America Armodafinil Tablets Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Armodafinil Tablets Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Armodafinil Tablets Sales and Revenue by Type (2020-2031)
7.4 Europe Armodafinil Tablets Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Armodafinil Tablets Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Armodafinil Tablets Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Armodafinil Tablets Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Armodafinil Tablets Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Armodafinil Tablets Sales and Revenue by Type (2020-2031)
9.4 Central and South America Armodafinil Tablets Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Armodafinil Tablets Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Armodafinil Tablets Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Armodafinil Tablets Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Armodafinil Tablets Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Cephalon
11.1.1 Cephalon Corporation Information
11.1.2 Cephalon Business Overview
11.1.3 Cephalon Armodafinil Tablets Product Models, Descriptions and Specifications
11.1.4 Cephalon Armodafinil Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Cephalon Armodafinil Tablets Sales by Product in 2024
11.1.6 Cephalon Armodafinil Tablets Sales by Application in 2024
11.1.7 Cephalon Armodafinil Tablets Sales by Geographic Area in 2024
11.1.8 Cephalon Armodafinil Tablets SWOT Analysis
11.1.9 Cephalon Recent Developments
11.2 Mylan
11.2.1 Mylan Corporation Information
11.2.2 Mylan Business Overview
11.2.3 Mylan Armodafinil Tablets Product Models, Descriptions and Specifications
11.2.4 Mylan Armodafinil Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Mylan Armodafinil Tablets Sales by Product in 2024
11.2.6 Mylan Armodafinil Tablets Sales by Application in 2024
11.2.7 Mylan Armodafinil Tablets Sales by Geographic Area in 2024
11.2.8 Mylan Armodafinil Tablets SWOT Analysis
11.2.9 Mylan Recent Developments
11.3 Natco Pharma
11.3.1 Natco Pharma Corporation Information
11.3.2 Natco Pharma Business Overview
11.3.3 Natco Pharma Armodafinil Tablets Product Models, Descriptions and Specifications
11.3.4 Natco Pharma Armodafinil Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Natco Pharma Armodafinil Tablets Sales by Product in 2024
11.3.6 Natco Pharma Armodafinil Tablets Sales by Application in 2024
11.3.7 Natco Pharma Armodafinil Tablets Sales by Geographic Area in 2024
11.3.8 Natco Pharma Armodafinil Tablets SWOT Analysis
11.3.9 Natco Pharma Recent Developments
11.4 Lupin
11.4.1 Lupin Corporation Information
11.4.2 Lupin Business Overview
11.4.3 Lupin Armodafinil Tablets Product Models, Descriptions and Specifications
11.4.4 Lupin Armodafinil Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Lupin Armodafinil Tablets Sales by Product in 2024
11.4.6 Lupin Armodafinil Tablets Sales by Application in 2024
11.4.7 Lupin Armodafinil Tablets Sales by Geographic Area in 2024
11.4.8 Lupin Armodafinil Tablets SWOT Analysis
11.4.9 Lupin Recent Developments
11.5 Aurobindo Pharma
11.5.1 Aurobindo Pharma Corporation Information
11.5.2 Aurobindo Pharma Business Overview
11.5.3 Aurobindo Pharma Armodafinil Tablets Product Models, Descriptions and Specifications
11.5.4 Aurobindo Pharma Armodafinil Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Aurobindo Pharma Armodafinil Tablets Sales by Product in 2024
11.5.6 Aurobindo Pharma Armodafinil Tablets Sales by Application in 2024
11.5.7 Aurobindo Pharma Armodafinil Tablets Sales by Geographic Area in 2024
11.5.8 Aurobindo Pharma Armodafinil Tablets SWOT Analysis
11.5.9 Aurobindo Pharma Recent Developments
11.6 Sandoz
11.6.1 Sandoz Corporation Information
11.6.2 Sandoz Business Overview
11.6.3 Sandoz Armodafinil Tablets Product Models, Descriptions and Specifications
11.6.4 Sandoz Armodafinil Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Sandoz Recent Developments
11.7 Actavis
11.7.1 Actavis Corporation Information
11.7.2 Actavis Business Overview
11.7.3 Actavis Armodafinil Tablets Product Models, Descriptions and Specifications
11.7.4 Actavis Armodafinil Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Actavis Recent Developments
11.8 Apotex
11.8.1 Apotex Corporation Information
11.8.2 Apotex Business Overview
11.8.3 Apotex Armodafinil Tablets Product Models, Descriptions and Specifications
11.8.4 Apotex Armodafinil Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Apotex Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Armodafinil Tablets Industry Chain
12.2 Armodafinil Tablets Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Armodafinil Tablets Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Armodafinil Tablets Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Armodafinil Tablets Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Armodafinil Tablets Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
1.1 Introduction to Armodafinil Tablets: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Armodafinil Tablets Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 50mg per Tablet
1.2.3 150mg per Tablet
1.2.4 200mg per Tablet
1.2.5 250mg per Tablet
1.3 Market Segmentation by Application
1.3.1 Global Armodafinil Tablets Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Narcolepsy
1.3.3 Obstructive Sleep Apnea
1.3.4 Shift Work Sleep Disorder
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Armodafinil Tablets Revenue Estimates and Forecasts 2020-2031
2.2 Global Armodafinil Tablets Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Armodafinil Tablets Sales Estimates and Forecasts 2020-2031
2.4 Global Armodafinil Tablets Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Armodafinil Tablets Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Armodafinil Tablets Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 50mg per Tablet Market Size by Manufacturers
3.5.2 150mg per Tablet Market Size by Manufacturers
3.5.3 200mg per Tablet Market Size by Manufacturers
3.5.4 250mg per Tablet Market Size by Manufacturers
3.6 Global Armodafinil Tablets Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Armodafinil Tablets Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Armodafinil Tablets Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Armodafinil Tablets Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Armodafinil Tablets Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Armodafinil Tablets Sales and Revenue by Type (2020-2031)
6.4 North America Armodafinil Tablets Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Armodafinil Tablets Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Armodafinil Tablets Sales and Revenue by Type (2020-2031)
7.4 Europe Armodafinil Tablets Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Armodafinil Tablets Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Armodafinil Tablets Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Armodafinil Tablets Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Armodafinil Tablets Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Armodafinil Tablets Sales and Revenue by Type (2020-2031)
9.4 Central and South America Armodafinil Tablets Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Armodafinil Tablets Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Armodafinil Tablets Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Armodafinil Tablets Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Armodafinil Tablets Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Cephalon
11.1.1 Cephalon Corporation Information
11.1.2 Cephalon Business Overview
11.1.3 Cephalon Armodafinil Tablets Product Models, Descriptions and Specifications
11.1.4 Cephalon Armodafinil Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Cephalon Armodafinil Tablets Sales by Product in 2024
11.1.6 Cephalon Armodafinil Tablets Sales by Application in 2024
11.1.7 Cephalon Armodafinil Tablets Sales by Geographic Area in 2024
11.1.8 Cephalon Armodafinil Tablets SWOT Analysis
11.1.9 Cephalon Recent Developments
11.2 Mylan
11.2.1 Mylan Corporation Information
11.2.2 Mylan Business Overview
11.2.3 Mylan Armodafinil Tablets Product Models, Descriptions and Specifications
11.2.4 Mylan Armodafinil Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Mylan Armodafinil Tablets Sales by Product in 2024
11.2.6 Mylan Armodafinil Tablets Sales by Application in 2024
11.2.7 Mylan Armodafinil Tablets Sales by Geographic Area in 2024
11.2.8 Mylan Armodafinil Tablets SWOT Analysis
11.2.9 Mylan Recent Developments
11.3 Natco Pharma
11.3.1 Natco Pharma Corporation Information
11.3.2 Natco Pharma Business Overview
11.3.3 Natco Pharma Armodafinil Tablets Product Models, Descriptions and Specifications
11.3.4 Natco Pharma Armodafinil Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Natco Pharma Armodafinil Tablets Sales by Product in 2024
11.3.6 Natco Pharma Armodafinil Tablets Sales by Application in 2024
11.3.7 Natco Pharma Armodafinil Tablets Sales by Geographic Area in 2024
11.3.8 Natco Pharma Armodafinil Tablets SWOT Analysis
11.3.9 Natco Pharma Recent Developments
11.4 Lupin
11.4.1 Lupin Corporation Information
11.4.2 Lupin Business Overview
11.4.3 Lupin Armodafinil Tablets Product Models, Descriptions and Specifications
11.4.4 Lupin Armodafinil Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Lupin Armodafinil Tablets Sales by Product in 2024
11.4.6 Lupin Armodafinil Tablets Sales by Application in 2024
11.4.7 Lupin Armodafinil Tablets Sales by Geographic Area in 2024
11.4.8 Lupin Armodafinil Tablets SWOT Analysis
11.4.9 Lupin Recent Developments
11.5 Aurobindo Pharma
11.5.1 Aurobindo Pharma Corporation Information
11.5.2 Aurobindo Pharma Business Overview
11.5.3 Aurobindo Pharma Armodafinil Tablets Product Models, Descriptions and Specifications
11.5.4 Aurobindo Pharma Armodafinil Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Aurobindo Pharma Armodafinil Tablets Sales by Product in 2024
11.5.6 Aurobindo Pharma Armodafinil Tablets Sales by Application in 2024
11.5.7 Aurobindo Pharma Armodafinil Tablets Sales by Geographic Area in 2024
11.5.8 Aurobindo Pharma Armodafinil Tablets SWOT Analysis
11.5.9 Aurobindo Pharma Recent Developments
11.6 Sandoz
11.6.1 Sandoz Corporation Information
11.6.2 Sandoz Business Overview
11.6.3 Sandoz Armodafinil Tablets Product Models, Descriptions and Specifications
11.6.4 Sandoz Armodafinil Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Sandoz Recent Developments
11.7 Actavis
11.7.1 Actavis Corporation Information
11.7.2 Actavis Business Overview
11.7.3 Actavis Armodafinil Tablets Product Models, Descriptions and Specifications
11.7.4 Actavis Armodafinil Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Actavis Recent Developments
11.8 Apotex
11.8.1 Apotex Corporation Information
11.8.2 Apotex Business Overview
11.8.3 Apotex Armodafinil Tablets Product Models, Descriptions and Specifications
11.8.4 Apotex Armodafinil Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Apotex Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Armodafinil Tablets Industry Chain
12.2 Armodafinil Tablets Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Armodafinil Tablets Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Armodafinil Tablets Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Armodafinil Tablets Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Armodafinil Tablets Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Armodafinil Tablets Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Armodafinil Tablets Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Armodafinil Tablets Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Armodafinil Tablets Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Armodafinil Tablets Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Armodafinil Tablets Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Armodafinil Tablets Sales by Region (2020-2025) & (K Units)
Table 8. Global Armodafinil Tablets Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Armodafinil Tablets Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Armodafinil Tablets Sales Share by Manufacturers (2020-2025)
Table 12. Global Armodafinil Tablets Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Armodafinil Tablets Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Armodafinil Tablets by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Armodafinil Tablets as of 2024)
Table 16. Global Armodafinil Tablets Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Armodafinil Tablets Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Armodafinil Tablets Manufacturing Base and Headquarters
Table 19. Global Armodafinil Tablets Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Armodafinil Tablets Sales by Type (2020-2025) & (K Units)
Table 23. Global Armodafinil Tablets Sales by Type (2026-2031) & (K Units)
Table 24. Global Armodafinil Tablets Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Armodafinil Tablets Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Armodafinil Tablets ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Armodafinil Tablets Sales by Application (2020-2025) & (K Units)
Table 29. Global Armodafinil Tablets Sales by Application (2026-2031) & (K Units)
Table 30. Armodafinil Tablets High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Armodafinil Tablets Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Armodafinil Tablets Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Armodafinil Tablets ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Armodafinil Tablets Growth Accelerators and Market Barriers
Table 37. North America Armodafinil Tablets Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Armodafinil Tablets Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Armodafinil Tablets Growth Accelerators and Market Barriers
Table 40. Europe Armodafinil Tablets Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Armodafinil Tablets Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Armodafinil Tablets Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Armodafinil Tablets Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Armodafinil Tablets Growth Accelerators and Market Barriers
Table 45. Southeast Asia Armodafinil Tablets Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Armodafinil Tablets Investment Opportunities and Key Challenges
Table 47. Central and South America Armodafinil Tablets Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Armodafinil Tablets Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Armodafinil Tablets Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Cephalon Corporation Information
Table 51. Cephalon Description and Major Businesses
Table 52. Cephalon Product Models, Descriptions and Specifications
Table 53. Cephalon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Cephalon Sales Value Proportion by Product in 2024
Table 55. Cephalon Sales Value Proportion by Application in 2024
Table 56. Cephalon Sales Value Proportion by Geographic Area in 2024
Table 57. Cephalon Armodafinil Tablets SWOT Analysis
Table 58. Cephalon Recent Developments
Table 59. Mylan Corporation Information
Table 60. Mylan Description and Major Businesses
Table 61. Mylan Product Models, Descriptions and Specifications
Table 62. Mylan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Mylan Sales Value Proportion by Product in 2024
Table 64. Mylan Sales Value Proportion by Application in 2024
Table 65. Mylan Sales Value Proportion by Geographic Area in 2024
Table 66. Mylan Armodafinil Tablets SWOT Analysis
Table 67. Mylan Recent Developments
Table 68. Natco Pharma Corporation Information
Table 69. Natco Pharma Description and Major Businesses
Table 70. Natco Pharma Product Models, Descriptions and Specifications
Table 71. Natco Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Natco Pharma Sales Value Proportion by Product in 2024
Table 73. Natco Pharma Sales Value Proportion by Application in 2024
Table 74. Natco Pharma Sales Value Proportion by Geographic Area in 2024
Table 75. Natco Pharma Armodafinil Tablets SWOT Analysis
Table 76. Natco Pharma Recent Developments
Table 77. Lupin Corporation Information
Table 78. Lupin Description and Major Businesses
Table 79. Lupin Product Models, Descriptions and Specifications
Table 80. Lupin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Lupin Sales Value Proportion by Product in 2024
Table 82. Lupin Sales Value Proportion by Application in 2024
Table 83. Lupin Sales Value Proportion by Geographic Area in 2024
Table 84. Lupin Armodafinil Tablets SWOT Analysis
Table 85. Lupin Recent Developments
Table 86. Aurobindo Pharma Corporation Information
Table 87. Aurobindo Pharma Description and Major Businesses
Table 88. Aurobindo Pharma Product Models, Descriptions and Specifications
Table 89. Aurobindo Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Aurobindo Pharma Sales Value Proportion by Product in 2024
Table 91. Aurobindo Pharma Sales Value Proportion by Application in 2024
Table 92. Aurobindo Pharma Sales Value Proportion by Geographic Area in 2024
Table 93. Aurobindo Pharma Armodafinil Tablets SWOT Analysis
Table 94. Aurobindo Pharma Recent Developments
Table 95. Sandoz Corporation Information
Table 96. Sandoz Description and Major Businesses
Table 97. Sandoz Product Models, Descriptions and Specifications
Table 98. Sandoz Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Sandoz Recent Developments
Table 100. Actavis Corporation Information
Table 101. Actavis Description and Major Businesses
Table 102. Actavis Product Models, Descriptions and Specifications
Table 103. Actavis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Actavis Recent Developments
Table 105. Apotex Corporation Information
Table 106. Apotex Description and Major Businesses
Table 107. Apotex Product Models, Descriptions and Specifications
Table 108. Apotex Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Apotex Recent Developments
Table 110. Key Raw Materials Distribution
Table 111. Raw Materials Key Suppliers
Table 112. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 113. Milestones in Production Technology Evolution
Table 114. Distributors List
Table 115. Market Trends and Market Evolution
Table 116. Market Drivers and Opportunities
Table 117. Market Challenges, Risks, and Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Armodafinil Tablets Product Picture
Figure 2. Global Armodafinil Tablets Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. 50mg per Tablet Product Picture
Figure 4. 150mg per Tablet Product Picture
Figure 5. 200mg per Tablet Product Picture
Figure 6. 250mg per Tablet Product Picture
Figure 7. Global Armodafinil Tablets Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Narcolepsy
Figure 9. Obstructive Sleep Apnea
Figure 10. Shift Work Sleep Disorder
Figure 11. Other
Figure 12. Armodafinil Tablets Report Years Considered
Figure 13. Global Armodafinil Tablets Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Armodafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 15. Global Armodafinil Tablets Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 16. Global Armodafinil Tablets Revenue Market Share by Region (2020-2031)
Figure 17. Global Armodafinil Tablets Sales (2020-2031) & (K Units)
Figure 18. Global Armodafinil Tablets Sales (CAGR) by Region (2020-2031) (K Units)
Figure 19. Global Armodafinil Tablets Sales Market Share by Region (2020-2031)
Figure 20. Top 5 and Top 10 Manufacturers Armodafinil Tablets Sales Volume Market Share in 2024
Figure 21. Global Armodafinil Tablets Revenue Market Share Ranking (2024)
Figure 22. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 23. 50mg per Tablet Revenue Market Share by Manufacturer in 2024
Figure 24. 150mg per Tablet Revenue Market Share by Manufacturer in 2024
Figure 25. 200mg per Tablet Revenue Market Share by Manufacturer in 2024
Figure 26. 250mg per Tablet Revenue Market Share by Manufacturer in 2024
Figure 27. Global Armodafinil Tablets Sales Market Share by Type (2020-2031)
Figure 28. Global Armodafinil Tablets Revenue Market Share by Type (2020-2031)
Figure 29. Global Armodafinil Tablets Sales Market Share by Application (2020-2031)
Figure 30. Global Armodafinil Tablets Revenue Market Share by Application (2020-2031)
Figure 31. North America Armodafinil Tablets Sales YoY (2020-2031) & (K Units)
Figure 32. North America Armodafinil Tablets Revenue YoY (2020-2031) & (US$ Million)
Figure 33. North America Top 5 Manufacturers Armodafinil Tablets Sales Revenue (US$ Million) in 2024
Figure 34. North America Armodafinil Tablets Sales Volume (K Units) by Type (2020- 2031)
Figure 35. North America Armodafinil Tablets Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 36. North America Armodafinil Tablets Sales Volume (K Units) by Application (2020-2031)
Figure 37. North America Armodafinil Tablets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 38. US Armodafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 39. Canada Armodafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 40. Mexico Armodafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 41. Europe Armodafinil Tablets Sales YoY (2020-2031) & (K Units)
Figure 42. Europe Armodafinil Tablets Revenue YoY (2020-2031) & (US$ Million)
Figure 43. Europe Top 5 Manufacturers Armodafinil Tablets Sales Revenue (US$ Million) in 2024
Figure 44. Europe Armodafinil Tablets Sales Volume (K Units) by Type (2020-2031)
Figure 45. Europe Armodafinil Tablets Sales Revenue (US$ Million) by Type (2020-2031)
Figure 46. Europe Armodafinil Tablets Sales Volume (K Units) by Application (2020-2031)
Figure 47. Europe Armodafinil Tablets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 48. Germany Armodafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 49. France Armodafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 50. U.K. Armodafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 51. Italy Armodafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 52. Russia Armodafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 53. Asia-Pacific Armodafinil Tablets Sales YoY (2020-2031) & (K Units)
Figure 54. Asia-Pacific Armodafinil Tablets Revenue YoY (2020-2031) & (US$ Million)
Figure 55. Asia-Pacific Top 8 Manufacturers Armodafinil Tablets Sales Revenue (US$ Million) in 2024
Figure 56. Asia-Pacific Armodafinil Tablets Sales Volume (K Units) by Type (2020- 2031)
Figure 57. Asia-Pacific Armodafinil Tablets Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 58. Asia-Pacific Armodafinil Tablets Sales Volume (K Units) by Application (2020-2031)
Figure 59. Asia-Pacific Armodafinil Tablets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 60. Indonesia Armodafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 61. Japan Armodafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 62. South Korea Armodafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 63. China Taiwan Armodafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 64. India Armodafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 65. Central and South America Armodafinil Tablets Sales YoY (2020-2031) & (K Units)
Figure 66. Central and South America Armodafinil Tablets Revenue YoY (2020-2031) & (US$ Million)
Figure 67. Central and South America Top 5 Manufacturers Armodafinil Tablets Sales Revenue (US$ Million) in 2024
Figure 68. Central and South America Armodafinil Tablets Sales Volume (K Units) by Type (2021-2031)
Figure 69. Central and South America Armodafinil Tablets Sales Revenue (US$ Million) by Type (2020-2031)
Figure 70. Central and South America Armodafinil Tablets Sales Volume (K Units) by Application (2020-2031)
Figure 71. Central and South America Armodafinil Tablets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 72. Brazil Armodafinil Tablets Revenue (2020-2025) & (US$ Million)
Figure 73. Argentina Armodafinil Tablets Revenue (2020-2025) & (US$ Million)
Figure 74. Middle East, and Africa Armodafinil Tablets Sales YoY (2020-2031) & (K Units)
Figure 75. Middle East and Africa Armodafinil Tablets Revenue YoY (2020-2031) & (US$ Million)
Figure 76. Middle East and Africa Top 5 Manufacturers Armodafinil Tablets Sales Revenue (US$ Million) in 2024
Figure 77. Middle East and Africa Armodafinil Tablets Sales Volume (K Units) by Type (2021-2031)
Figure 78. South America Armodafinil Tablets Sales Revenue (US$ Million) by Type (2020-2031)
Figure 79. Middle East and Africa Armodafinil Tablets Sales Volume (K Units) by Application (2020-2031)
Figure 80. Middle East and Africa Armodafinil Tablets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 81. GCC Countries Armodafinil Tablets Revenue (2020-2025) & (US$ Million)
Figure 82. Turkey Armodafinil Tablets Revenue (2020-2025) & (US$ Million)
Figure 83. Egypt Armodafinil Tablets Revenue (2020-2025) & (US$ Million)
Figure 84. South Africa Armodafinil Tablets Revenue (2020-2025) & (US$ Million)
Figure 85. Armodafinil Tablets Industry Chain Mapping
Figure 86. Regional Armodafinil Tablets Manufacturing Base Distribution (%)
Figure 87. Global Armodafinil Tablets Production Market Share by Region (2020-2031)
Figure 88. Armodafinil Tablets Production Process
Figure 89. Regional Armodafinil Tablets Production Cost Structure
Figure 90. Channels of Distribution (Direct Vs Distribution)
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed
Table 1. Global Armodafinil Tablets Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Armodafinil Tablets Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Armodafinil Tablets Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Armodafinil Tablets Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Armodafinil Tablets Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Armodafinil Tablets Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Armodafinil Tablets Sales by Region (2020-2025) & (K Units)
Table 8. Global Armodafinil Tablets Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Armodafinil Tablets Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Armodafinil Tablets Sales Share by Manufacturers (2020-2025)
Table 12. Global Armodafinil Tablets Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Armodafinil Tablets Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Armodafinil Tablets by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Armodafinil Tablets as of 2024)
Table 16. Global Armodafinil Tablets Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Armodafinil Tablets Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Armodafinil Tablets Manufacturing Base and Headquarters
Table 19. Global Armodafinil Tablets Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Armodafinil Tablets Sales by Type (2020-2025) & (K Units)
Table 23. Global Armodafinil Tablets Sales by Type (2026-2031) & (K Units)
Table 24. Global Armodafinil Tablets Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Armodafinil Tablets Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Armodafinil Tablets ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Armodafinil Tablets Sales by Application (2020-2025) & (K Units)
Table 29. Global Armodafinil Tablets Sales by Application (2026-2031) & (K Units)
Table 30. Armodafinil Tablets High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Armodafinil Tablets Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Armodafinil Tablets Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Armodafinil Tablets ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Armodafinil Tablets Growth Accelerators and Market Barriers
Table 37. North America Armodafinil Tablets Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Armodafinil Tablets Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Armodafinil Tablets Growth Accelerators and Market Barriers
Table 40. Europe Armodafinil Tablets Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Armodafinil Tablets Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Armodafinil Tablets Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Armodafinil Tablets Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Armodafinil Tablets Growth Accelerators and Market Barriers
Table 45. Southeast Asia Armodafinil Tablets Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Armodafinil Tablets Investment Opportunities and Key Challenges
Table 47. Central and South America Armodafinil Tablets Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Armodafinil Tablets Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Armodafinil Tablets Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Cephalon Corporation Information
Table 51. Cephalon Description and Major Businesses
Table 52. Cephalon Product Models, Descriptions and Specifications
Table 53. Cephalon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Cephalon Sales Value Proportion by Product in 2024
Table 55. Cephalon Sales Value Proportion by Application in 2024
Table 56. Cephalon Sales Value Proportion by Geographic Area in 2024
Table 57. Cephalon Armodafinil Tablets SWOT Analysis
Table 58. Cephalon Recent Developments
Table 59. Mylan Corporation Information
Table 60. Mylan Description and Major Businesses
Table 61. Mylan Product Models, Descriptions and Specifications
Table 62. Mylan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Mylan Sales Value Proportion by Product in 2024
Table 64. Mylan Sales Value Proportion by Application in 2024
Table 65. Mylan Sales Value Proportion by Geographic Area in 2024
Table 66. Mylan Armodafinil Tablets SWOT Analysis
Table 67. Mylan Recent Developments
Table 68. Natco Pharma Corporation Information
Table 69. Natco Pharma Description and Major Businesses
Table 70. Natco Pharma Product Models, Descriptions and Specifications
Table 71. Natco Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Natco Pharma Sales Value Proportion by Product in 2024
Table 73. Natco Pharma Sales Value Proportion by Application in 2024
Table 74. Natco Pharma Sales Value Proportion by Geographic Area in 2024
Table 75. Natco Pharma Armodafinil Tablets SWOT Analysis
Table 76. Natco Pharma Recent Developments
Table 77. Lupin Corporation Information
Table 78. Lupin Description and Major Businesses
Table 79. Lupin Product Models, Descriptions and Specifications
Table 80. Lupin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Lupin Sales Value Proportion by Product in 2024
Table 82. Lupin Sales Value Proportion by Application in 2024
Table 83. Lupin Sales Value Proportion by Geographic Area in 2024
Table 84. Lupin Armodafinil Tablets SWOT Analysis
Table 85. Lupin Recent Developments
Table 86. Aurobindo Pharma Corporation Information
Table 87. Aurobindo Pharma Description and Major Businesses
Table 88. Aurobindo Pharma Product Models, Descriptions and Specifications
Table 89. Aurobindo Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Aurobindo Pharma Sales Value Proportion by Product in 2024
Table 91. Aurobindo Pharma Sales Value Proportion by Application in 2024
Table 92. Aurobindo Pharma Sales Value Proportion by Geographic Area in 2024
Table 93. Aurobindo Pharma Armodafinil Tablets SWOT Analysis
Table 94. Aurobindo Pharma Recent Developments
Table 95. Sandoz Corporation Information
Table 96. Sandoz Description and Major Businesses
Table 97. Sandoz Product Models, Descriptions and Specifications
Table 98. Sandoz Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Sandoz Recent Developments
Table 100. Actavis Corporation Information
Table 101. Actavis Description and Major Businesses
Table 102. Actavis Product Models, Descriptions and Specifications
Table 103. Actavis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Actavis Recent Developments
Table 105. Apotex Corporation Information
Table 106. Apotex Description and Major Businesses
Table 107. Apotex Product Models, Descriptions and Specifications
Table 108. Apotex Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Apotex Recent Developments
Table 110. Key Raw Materials Distribution
Table 111. Raw Materials Key Suppliers
Table 112. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 113. Milestones in Production Technology Evolution
Table 114. Distributors List
Table 115. Market Trends and Market Evolution
Table 116. Market Drivers and Opportunities
Table 117. Market Challenges, Risks, and Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Armodafinil Tablets Product Picture
Figure 2. Global Armodafinil Tablets Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. 50mg per Tablet Product Picture
Figure 4. 150mg per Tablet Product Picture
Figure 5. 200mg per Tablet Product Picture
Figure 6. 250mg per Tablet Product Picture
Figure 7. Global Armodafinil Tablets Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Narcolepsy
Figure 9. Obstructive Sleep Apnea
Figure 10. Shift Work Sleep Disorder
Figure 11. Other
Figure 12. Armodafinil Tablets Report Years Considered
Figure 13. Global Armodafinil Tablets Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Armodafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 15. Global Armodafinil Tablets Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 16. Global Armodafinil Tablets Revenue Market Share by Region (2020-2031)
Figure 17. Global Armodafinil Tablets Sales (2020-2031) & (K Units)
Figure 18. Global Armodafinil Tablets Sales (CAGR) by Region (2020-2031) (K Units)
Figure 19. Global Armodafinil Tablets Sales Market Share by Region (2020-2031)
Figure 20. Top 5 and Top 10 Manufacturers Armodafinil Tablets Sales Volume Market Share in 2024
Figure 21. Global Armodafinil Tablets Revenue Market Share Ranking (2024)
Figure 22. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 23. 50mg per Tablet Revenue Market Share by Manufacturer in 2024
Figure 24. 150mg per Tablet Revenue Market Share by Manufacturer in 2024
Figure 25. 200mg per Tablet Revenue Market Share by Manufacturer in 2024
Figure 26. 250mg per Tablet Revenue Market Share by Manufacturer in 2024
Figure 27. Global Armodafinil Tablets Sales Market Share by Type (2020-2031)
Figure 28. Global Armodafinil Tablets Revenue Market Share by Type (2020-2031)
Figure 29. Global Armodafinil Tablets Sales Market Share by Application (2020-2031)
Figure 30. Global Armodafinil Tablets Revenue Market Share by Application (2020-2031)
Figure 31. North America Armodafinil Tablets Sales YoY (2020-2031) & (K Units)
Figure 32. North America Armodafinil Tablets Revenue YoY (2020-2031) & (US$ Million)
Figure 33. North America Top 5 Manufacturers Armodafinil Tablets Sales Revenue (US$ Million) in 2024
Figure 34. North America Armodafinil Tablets Sales Volume (K Units) by Type (2020- 2031)
Figure 35. North America Armodafinil Tablets Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 36. North America Armodafinil Tablets Sales Volume (K Units) by Application (2020-2031)
Figure 37. North America Armodafinil Tablets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 38. US Armodafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 39. Canada Armodafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 40. Mexico Armodafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 41. Europe Armodafinil Tablets Sales YoY (2020-2031) & (K Units)
Figure 42. Europe Armodafinil Tablets Revenue YoY (2020-2031) & (US$ Million)
Figure 43. Europe Top 5 Manufacturers Armodafinil Tablets Sales Revenue (US$ Million) in 2024
Figure 44. Europe Armodafinil Tablets Sales Volume (K Units) by Type (2020-2031)
Figure 45. Europe Armodafinil Tablets Sales Revenue (US$ Million) by Type (2020-2031)
Figure 46. Europe Armodafinil Tablets Sales Volume (K Units) by Application (2020-2031)
Figure 47. Europe Armodafinil Tablets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 48. Germany Armodafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 49. France Armodafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 50. U.K. Armodafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 51. Italy Armodafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 52. Russia Armodafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 53. Asia-Pacific Armodafinil Tablets Sales YoY (2020-2031) & (K Units)
Figure 54. Asia-Pacific Armodafinil Tablets Revenue YoY (2020-2031) & (US$ Million)
Figure 55. Asia-Pacific Top 8 Manufacturers Armodafinil Tablets Sales Revenue (US$ Million) in 2024
Figure 56. Asia-Pacific Armodafinil Tablets Sales Volume (K Units) by Type (2020- 2031)
Figure 57. Asia-Pacific Armodafinil Tablets Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 58. Asia-Pacific Armodafinil Tablets Sales Volume (K Units) by Application (2020-2031)
Figure 59. Asia-Pacific Armodafinil Tablets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 60. Indonesia Armodafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 61. Japan Armodafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 62. South Korea Armodafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 63. China Taiwan Armodafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 64. India Armodafinil Tablets Revenue (2020-2031) & (US$ Million)
Figure 65. Central and South America Armodafinil Tablets Sales YoY (2020-2031) & (K Units)
Figure 66. Central and South America Armodafinil Tablets Revenue YoY (2020-2031) & (US$ Million)
Figure 67. Central and South America Top 5 Manufacturers Armodafinil Tablets Sales Revenue (US$ Million) in 2024
Figure 68. Central and South America Armodafinil Tablets Sales Volume (K Units) by Type (2021-2031)
Figure 69. Central and South America Armodafinil Tablets Sales Revenue (US$ Million) by Type (2020-2031)
Figure 70. Central and South America Armodafinil Tablets Sales Volume (K Units) by Application (2020-2031)
Figure 71. Central and South America Armodafinil Tablets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 72. Brazil Armodafinil Tablets Revenue (2020-2025) & (US$ Million)
Figure 73. Argentina Armodafinil Tablets Revenue (2020-2025) & (US$ Million)
Figure 74. Middle East, and Africa Armodafinil Tablets Sales YoY (2020-2031) & (K Units)
Figure 75. Middle East and Africa Armodafinil Tablets Revenue YoY (2020-2031) & (US$ Million)
Figure 76. Middle East and Africa Top 5 Manufacturers Armodafinil Tablets Sales Revenue (US$ Million) in 2024
Figure 77. Middle East and Africa Armodafinil Tablets Sales Volume (K Units) by Type (2021-2031)
Figure 78. South America Armodafinil Tablets Sales Revenue (US$ Million) by Type (2020-2031)
Figure 79. Middle East and Africa Armodafinil Tablets Sales Volume (K Units) by Application (2020-2031)
Figure 80. Middle East and Africa Armodafinil Tablets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 81. GCC Countries Armodafinil Tablets Revenue (2020-2025) & (US$ Million)
Figure 82. Turkey Armodafinil Tablets Revenue (2020-2025) & (US$ Million)
Figure 83. Egypt Armodafinil Tablets Revenue (2020-2025) & (US$ Million)
Figure 84. South Africa Armodafinil Tablets Revenue (2020-2025) & (US$ Million)
Figure 85. Armodafinil Tablets Industry Chain Mapping
Figure 86. Regional Armodafinil Tablets Manufacturing Base Distribution (%)
Figure 87. Global Armodafinil Tablets Production Market Share by Region (2020-2031)
Figure 88. Armodafinil Tablets Production Process
Figure 89. Regional Armodafinil Tablets Production Cost Structure
Figure 90. Channels of Distribution (Direct Vs Distribution)
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oral Antianginal Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Polyester BCF Yarns Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Glass Mat Reinforced Thermoplastics (GMT) for Automotive Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232